Not really. CYP has had plenty of 400-600K days in 2024 on little news.
You like myopically bragging about MSB's volumes vs CYP. Perhaps you should conversely ask yourself if some of those volumes look at alternative less richly priced stem cell investments on MSB's hopefully forthcoming approval, what just a fraction might do in the likes of less liquid CYP.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
-0.005(3.13%) |
Mkt cap ! $35.02M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.5¢ | 15.5¢ | $22.43K | 139.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 58708 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 9763 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |